A Randomized Open-Label Comparison of the Impact of Aripiprazole Versus Risperidone on Sexual Functioning (RAS Study)

被引:11
|
作者
de Boer, Marrit K. [1 ]
Wiersma, Durk [1 ]
Bous, Johan
Sytema, Sjoerd [1 ]
van der Moolen, Andrea E. G. M. [2 ]
Wilffert, Bob [3 ]
Hamamura, Takashi [4 ]
Knegtering, Henderikus [5 ,6 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Rob Giel Res Ctr, Groningen, Netherlands
[2] Univ Groningen, Dept Med Sociol, Groningen, Netherlands
[3] Univ Groningen, Dept Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands
[4] Hamamura Clin, Kurashiki, Okayama, Japan
[5] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Neuroimaging Ctr Groningen, Groningen, Netherlands
[6] Lentis Fdn Mental Healthcare Groningen, Groningen, Netherlands
关键词
INDUCED HYPERPROLACTINEMIA; ANTIPSYCHOTICS; OLANZAPINE; DISORDERS;
D O I
10.1097/JCP.0b013e318222bb29
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:523 / 525
页数:3
相关论文
共 50 条
  • [31] Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia
    Maat, Arija
    Cahn, Wiepke
    Gijsman, Harm J.
    Hovens, Johannes E.
    Kahn, Rene S.
    Aleman, Andre
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (04) : 575 - 584
  • [32] Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial
    Kim, Sung-Wan
    Chung, Young-Chul
    Lee, Yo-Han
    Lee, Jeong-Hoon
    Kim, Seon-Young
    Bae, Kyung-Yeol
    Kim, Jae-Min
    Shin, Il-Seon
    Yoon, Jin-Sang
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (05) : 267 - 274
  • [33] Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
    Zhao, Jingyuan
    Song, Xueqin
    Ai, Xiaoqing
    Gu, Xiaojing
    Huang, Guangbiao
    Li, Xue
    Pang, Lijuan
    Ding, Minli
    Ding, Shuang
    Lv, Luxian
    PLOS ONE, 2015, 10 (10):
  • [34] Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: A randomized, open-label, controlled trial
    Kim, S. -W.
    Chung, Y. -C.
    Lee, Y. -H.
    Lee, J. -H.
    Kim, S. -Y.
    Bae, K-Y.
    Jang, J. -E.
    Kim, J. -M.
    Shin, I. -S.
    Yoon, J. -S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 53 - 53
  • [35] A prospective open-label study of aripiprazole in fragile X syndrome
    Erickson, Craig A.
    Stigler, Kimberly A.
    Wink, Logan K.
    Mullett, Jennifer E.
    Kohn, Arlene
    Posey, David J.
    McDougle, Christopher J.
    PSYCHOPHARMACOLOGY, 2011, 216 (01) : 85 - 90
  • [36] Bupropion improves sexual functioning in depressed minority women - An open-label switch study
    Dobkin, RD
    Menza, M
    Marin, H
    Allen, LA
    Rousso, R
    Leiblum, SR
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (01) : 21 - 26
  • [37] A prospective open-label study of aripiprazole in fragile X syndrome
    Craig A. Erickson
    Kimberly A. Stigler
    Logan K. Wink
    Jennifer E. Mullett
    Arlene Kohn
    David J. Posey
    Christopher J. McDougle
    Psychopharmacology, 2011, 216 : 85 - 90
  • [38] Comparative study for the efficacy and tolerability of topiramate versus divalproex in combination with risperidone for the treatment of acute mania: A randomized open-label study in Korea
    Bahk, W
    Shin, Y
    Woo, J
    Yoon, B
    Lee, J
    Jon, D
    Chung, S
    Choi, S
    Paik, I
    Pae, C
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S155 - S155
  • [39] EVALUATION OF COGNITIVE FUNCTION IN PATIENTS SWITCHED FROM RISPERIDONE TO ARIPIPRAZOLE USING DIFFERENT TITRATION STRATEGIES: AN OPEN-LABEL STUDY
    Rykmans, V.
    Kahn, J. P.
    Dillenschneider, A.
    Modell, S.
    Werner, C.
    Kerselaers, W.
    Loze, J. Y.
    McQuade, R. D.
    Carson, W. H.
    Lissens, J.
    Sanchez, R.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 326 - 326
  • [40] An open-label pilot study of risperidone in the treatment of methamphetamine dependence
    Meredith, Charles W.
    Jaffe, Craig
    Yanasak, Elisia
    Cherrier, Monique
    Saxon, Andrew J.
    JOURNAL OF PSYCHOACTIVE DRUGS, 2007, 39 (02) : 167 - 172